Have a personal or library account? Click to login
Management of multiple myeloma in a patient with haemophilia with concurrent emicizumab – case report Cover

Management of multiple myeloma in a patient with haemophilia with concurrent emicizumab – case report

The Journal of Haemophilia Practice
Volume 8 (2021): Issue 1 (January 2021)
By: Elizabeth Davies,  Luke Carter-Brzezinski,  Margarita Traintafillou,  Rachel Brown and  Charles R M Hay  
Open Access
|Dec 2021

Figures & Tables

As people with haemophilia are living longer, there is a need to understand how to manage conditions associated with increased age, such as multiple myeloma, where standard treatment protocols involve the use of antithrombotic prophylaxis© Shutterstock
As people with haemophilia are living longer, there is a need to understand how to manage conditions associated with increased age, such as multiple myeloma, where standard treatment protocols involve the use of antithrombotic prophylaxis© Shutterstock

Figure 1

Patient history timeline
Patient history timeline
DOI: https://doi.org/10.2478/jhp-2021-0016 | Journal eISSN: 2055-3390
Journal RSS Feed
Language: English
Page range: 136 - 140
Published on: Dec 22, 2021
Published by: Haemnet Ltd
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
emicizumab,
myeloma,
thromboprophylaxis,
thalidomide,
lenalidomide
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Clinical medicine, other,
Pharmacy,
Pharmacology

© 2021 Elizabeth Davies, Luke Carter-Brzezinski, Margarita Traintafillou, Rachel Brown, Charles R M Hay, published by Haemnet Ltd
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 8 (2021): Issue 1 (January 2021)Next article